title: Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis.
abstract: Peritoneal dialysis therapy has increased in popularity since the end of the 1970s. This method provides a patient survival rate equivalent to hemodialysis and better preservation of residual renal function. However, technique failure by peritonitis, and ultrafiltration failure, which is a multifactorial complication that can affect up to 40% of patients after 3 years of therapy. Encapsulant peritoneal sclerosis is an extreme and potentially fatal manifestation. Causes of inflammation in peritoneal dialysis range from traditional factors to those related to chronic kidney disease per se, as well as from the peritoneal dialysis treatment, including the peritoneal dialysis catheter, dialysis solution, and infectious peritonitis. Peritoneal inflammation generated causes significant structural alterations including: thickening and cubic transformation of mesothelial cells, fibrin deposition, fibrous capsule formation, perivascular bleeding, and interstitial fibrosis. Structural alterations of the peritoneal membrane described above result in clinical and functional changes. One of these clinical manifestations is ultrafiltration failure and can occur in up to 30% of patients on PD after five years of treatment. An understanding of the mechanisms involved in peritoneal inflammation is fundamental to improve patient survival and provide a better quality of life.
authors.affiliation: School of Medicine, Pontifical Catholic University of Paraná, State University of Ponta Grossa, 80215-901 Curitiba, PR, Brazil.
authors.forename: Gilberto
authors.initials: G
authors.lastname: Baroni
authors.forename: Adriana
authors.initials: A
authors.lastname: Schuinski
authors.forename: Thyago P
authors.initials: TP
authors.lastname: de Moraes
authors.forename: Fernando
authors.initials: F
authors.lastname: Meyer
authors.forename: Roberto
authors.initials: R
authors.lastname: Pecoits-Filho
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D002462:Cell Membrane / Q000378:metabolism / Q000473:pathology*; D015314:Dialysis Solutions; D006801:Humans; D007249:Inflammation; D007676:Kidney Failure, Chronic / Q000473:pathology / Q000628:therapy; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000379:methods*; D010537:Peritoneum / Q000473:pathology*; D011788:Quality of Life; D051381:Rats
chemical_list: D001672:Biocompatible Materials; D015314:Dialysis Solutions